|
26/06/2025
|
07:00
|
Cancellation - Maxcyte Inc
|
RNS
|
|
25/06/2025
|
07:00
|
Last Day of Dealings on AIM
|
RNS
|
|
23/06/2025
|
18:00
|
MaxCyte
|
RNS
|
|
19/06/2025
|
07:00
|
Result of Annual General Meeting
|
RNS
|
|
12/06/2025
|
07:00
|
Holding(s) in Company
|
RNS
|
|
11/06/2025
|
07:00
|
MaxCyte and Ori Biotech Announce Collaboration
|
RNS
|
|
06/06/2025
|
09:33
|
Holding(s) in Company
|
RNS
|
|
05/06/2025
|
14:16
|
Holding(s) in Company
|
RNS
|
|
02/06/2025
|
17:14
|
Total Voting Rights
|
RNS
|
|
02/06/2025
|
16:17
|
Holding(s) in Company
|
RNS
|
|
29/05/2025
|
07:06
|
Holding(s) in Company
|
RNS
|
|
23/05/2025
|
16:52
|
Holding(s) in Company
|
RNS
|
|
23/05/2025
|
16:26
|
Holding(s) in Company
|
RNS
|
|
23/05/2025
|
07:00
|
Holding(s) in Company
|
RNS
|
|
19/05/2025
|
18:05
|
Holding(s) in Company
|
RNS
|
|
16/05/2025
|
15:12
|
Holding(s) in Company
|
RNS
|
|
09/05/2025
|
07:00
|
Filing of Form 10-Q
|
RNS
|
|
08/05/2025
|
07:00
|
First Quarter 2025 Financial Results
|
RNS
|
|
02/05/2025
|
16:40
|
Total Voting Rights
|
RNS
|
|
28/04/2025
|
07:00
|
Filing of definitive proxy statement
|
RNS
|
|
22/04/2025
|
14:43
|
Holding(s) in Company
|
RNS
|
|
22/04/2025
|
14:37
|
Holding(s) in Company
|
RNS
|
|
15/04/2025
|
17:00
|
Holding(s) in Company
|
RNS
|
|
15/04/2025
|
07:00
|
Proposed cancellation of trading on AIM
|
RNS
|
|
14/04/2025
|
09:17
|
Holding(s) in Company
|
RNS
|
|
10/04/2025
|
07:00
|
MaxCyte to Report Q1 2025 Results on May 7, 2025
|
RNS
|
|
08/04/2025
|
15:35
|
Holding(s) in Company
|
RNS
|
|
01/04/2025
|
17:57
|
Total Voting Rights
|
RNS
|
|
26/03/2025
|
10:14
|
Correction: Vesting of RSUs and PDMR Dealing
|
RNS
|
|
26/03/2025
|
07:00
|
Vesting of RSUs and PDMR Dealing
|
RNS
|
|
25/03/2025
|
10:30
|
Holding(s) in Company
|
RNS
|
|
25/03/2025
|
10:28
|
Holding(s) in Company
|
RNS
|
|
25/03/2025
|
10:26
|
Holding(s) in Company
|
RNS
|
|
25/03/2025
|
10:22
|
Holding(s) in Company
|
RNS
|
|
24/03/2025
|
09:06
|
Grant of Options, RSUs and PSUs and PDMR Dealing
|
RNS
|
|
19/03/2025
|
14:07
|
Holding(s) in Company
|
RNS
|
|
12/03/2025
|
07:01
|
Filing of Form 10-K for FY ended December 31, 2024
|
RNS
|
|
12/03/2025
|
07:00
|
Q4 & FY 2024 Financial Results
|
RNS
|
|
04/03/2025
|
15:38
|
Total Voting Rights
|
RNS
|
|
19/02/2025
|
15:23
|
Holding(s) in Company
|
RNS
|
|
14/02/2025
|
17:05
|
Holding(s) in Company
|
RNS
|
|
13/02/2025
|
16:12
|
Holding(s) in Company
|
RNS
|
|
13/02/2025
|
14:52
|
Holding(s) in Company
|
RNS
|
|
12/02/2025
|
07:00
|
Strategic Platform License with TG Therapeutics
|
RNS
|
|
07/02/2025
|
07:00
|
Notice of Results
|
RNS
|
|
04/02/2025
|
07:00
|
Total Voting Rights
|
RNS
|
|
31/01/2025
|
15:18
|
Exercise of options and PDMR dealing
|
RNS
|
|
30/01/2025
|
07:00
|
MaxCyte® Acquires SeQure Dx
|
RNS
|
|
29/01/2025
|
15:05
|
Holding(s) in Company
|
RNS
|
|
22/01/2025
|
14:25
|
Holding(s) in Company
|
RNS
|